Email this page
Print this pageGonal–f® (follitropin alfa for injection)
Understanding Gonal–f®
Gonal–f® is a highly pure, recombinant form of human follicle stimulating hormone (rFSH), which is the hormone responsible for stimulating the production of egg-containing follicles in women and sperm in men.
Gonal–f® is most commonly used in infertility treatments such as Ovulation Induction (OI) and Advanced Reproductive Technologies (ART), such as In Vitro Fertilization (IVF). If you are undergoing OI or ART, Gonal–f® may be used to supplement or replace naturally-occurring FSH and help you produce eggs.
Gonal–f® is the only FSH available in three dosing presentations of a ready-to-use multiple dose pen, as well as multiple dose and single dose vials. Gonal–f® is available in liquid and powder form as the following:
- Gonal–f® RFF Pen (follitropin alfa injection)
- Gonal–f® (follitropin alfa for injection) Multi-Dose vial
- Gonal–f® RFF (follitropin alfa for injection) 75 IU vial
In a recent survey1, 2 out of 3 patients* preferred the Gonal–f® RFF Pen to other FSH injection devices. The Gonal–f® RFF Pen was the pen delivery system a majority of women preferred1.
Talk to your doctor and find out how you can get started on Gonal–f® today!
Ovulation Induction (OI) Treatment
View the day–by–day animation of a woman's cycle while undergoing Ovulation Induction (OI)
Assisted Reproductive Technologies (ART) Treatments
1 Weiss N. Gonadotrophin products: empowering patients to choose the product that meets their needs. Reprod Biomed Online. 2007;15(1):31-37
* patients who stated a preference
Patient preference for Gonal–f® RFF Pen over Follistim® Pen and vials/ampules was also documented in a separate study by Welcker et al.
Welcker JT, on behalf of the German Gonal-f FbM Pen Study Group. Analysis of an observational study on the routine use of follitropin alfa in a prefilled ready to use injection pen in ovulation induction and intra-uterine insemination cycles [abstract]. Fertil Steril. 2006;86(suppl 2):S410. Abstract P-747
RFF: Revised Formulation Female
Important Safety Information
Gonal–f® should only be prescribed by doctors specializing in infertility or reproductive health. Gonal–f® can cause serious side effects including: ovarian hyperstimulation syndrome (OHSS), with or without blood vessel and lung complications and multiple births. Gonal–f® should not be used in patients who are allergic to recombinant FSH products, have primary gonadal failure, have uncontrolled thyroid or adrenal problems, have cancer of the sex organs, have a pituitary tumor or other tumor in their brain, have abnormal bleeding from the uterus or vagina or are pregnant or think they may be pregnant. The most common side effects in patients taking Gonal–f® include headache, upset stomach, breast discomfort and injection discomfort.
- Full Prescribing Information for the Gonal–f® RFF Pen (follitropin alfa injection) (126 KB)
- Full Prescribing Information for Gonal–f® (follitropin alfa for injection) Multi–Dose (417 KB)
- Prescribing Information for Gonal–f® RFF (follitropin alfa for injection) 75 IU vial (117 KB)
Looking for definitions for fertility terms? Visit our Glossary.
